From: Are cancer patients better off if they participate in clinical trials? A mixed methods study
Nurse (%) (n = 31) | Physician (%) (n = 26) | Total (%) (n = 57) | |
---|---|---|---|
Country | |||
Denmark | 19 (61,3) | 17 (65,4) | 36 (63,1) |
Sweden | 12 (38,7) | 9 (34,6) | 21 (36,9) |
Sex | |||
Female | 29 (93,5) | 18 (69,2) | 47 (82,5) |
Male | 2 (6,5) | 8 (30,8) | 9 (17,5) |
Age | |||
≤ 30–39 | 11 (35,8) | 8 (30,8) | 18 (33,3) |
40–49 | 10 (32,1) | 11 (42,3) | 22 (38,6) |
≤ 50–59 | 10 (32,1) | 7 (26,9) | 17 (29,7) |
Education | |||
Bachelor (3 years) | 22 (71,0) | – | 22 (38,6) |
Specialist nurses | 9 (29,0) | – | 9 (15,7) |
Physicians (≥5 years) | – | 9 (34,6) | 9 (15,7) |
PhD | – | 17 (65,4) | 17 (29,8) |
Years as nurse/physician | |||
Mean | 14,9 (0,3 to 35) | 16,4 (1 to | 15,5 (0,3 to |
≤ 10 | 13 (42,0) | 8 (30,7) | 21 (36,0) |
> 10 | 7 (22,5) | 9 (34,6) | 16 (28,0) |
> 20 | 11(35,5) | 9 (34,6) | 20 (36,0) |
Years in oncology/ haematology | |||
Mean | 11,2 (0,3 to 35) | 7,4 (1 to 40) | 9,5 (0,3 to 40) |
≤ 10 | 17 (54,8) | 13 (50,0) | 30 (52,6) |
> 10 | 8 (25,8) | 7 (27,0) | 15 (26,3) |
> 20 | 6 (19,3) | 6 (23,0) | 12 (21,1) |
Clinical trial setting | |||
Phase I | 13 (41,9) | 11 (42,3) | 24 (42,1) |
Phase II | 14 (41,1) | 16 (61,5) | 30 (52,6) |
Phase III | 27 (87,0) | 24 (92,3) | 51 (89,5) |